These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8708722

  • 1. Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer.
    Patt YZ, Jones DV, Hoque A, Lozano R, Markowitz A, Raijman I, Lynch P, Charnsangavej C.
    J Clin Oncol; 1996 Aug; 14(8):2311-5. PubMed ID: 8708722
    [Abstract] [Full Text] [Related]

  • 2. Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.
    Patt YZ, Hassan MM, Lozano RD, Waugh KA, Hoque AM, Frome AI, Lahoti S, Ellis L, Vauthey JN, Curley SA, Schnirer II, Raijman I.
    Clin Cancer Res; 2001 Nov; 7(11):3375-80. PubMed ID: 11705850
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
    Patt YZ, Hoque A, Lozano R, Pozdur R, Chase J, Carrasco H, Chuang V, Delpassand ES, Ellis L, Curley S, Roh M, Jones DV.
    J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma.
    Patt YZ, Hassan MM, Lozano RD, Brown TD, Vauthey JN, Curley SA, Ellis LM.
    J Clin Oncol; 2003 Feb 01; 21(3):421-7. PubMed ID: 12560429
    [Abstract] [Full Text] [Related]

  • 7. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
    Cantore M, Mambrini A, Fiorentini G, Rabbi C, Zamagni D, Caudana R, Pennucci C, Sanguinetti F, Lombardi M, Nicoli N.
    Cancer; 2005 Apr 01; 103(7):1402-7. PubMed ID: 15726542
    [Abstract] [Full Text] [Related]

  • 8. Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
    Alberts SR, Al-Khatib H, Mahoney MR, Burgart L, Cera PJ, Flynn PJ, Finch TR, Levitt R, Windschitl HE, Knost JA, Tschetter LK.
    Cancer; 2005 Jan 01; 103(1):111-8. PubMed ID: 15558814
    [Abstract] [Full Text] [Related]

  • 9. Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma.
    Yashima Y, Sato S, Kawai T, Sugimoto T, Sato T, Kanda M, Obi S.
    Hepatol Int; 2015 Jan 01; 9(1):142-8. PubMed ID: 25788388
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.
    Whittington R, Neuberg D, Tester WJ, Benson AB, Haller DG.
    J Clin Oncol; 1995 Jan 01; 13(1):227-32. PubMed ID: 7799024
    [Abstract] [Full Text] [Related]

  • 12. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
    Grem JL, McAtee N, Murphy RF, Balis FM, Steinberg SM, Hamilton JM, Sorensen JM, Sartor O, Kramer BS, Goldstein LJ.
    J Clin Oncol; 1991 Oct 01; 9(10):1811-20. PubMed ID: 1919632
    [Abstract] [Full Text] [Related]

  • 13. Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
    Pazdur R, Ajani JA, Patt YZ, Gomez J, Bready B, Levin B.
    Cancer; 1993 Feb 15; 71(4):1214-8. PubMed ID: 8435795
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
    J Clin Oncol; 1995 Apr 15; 13(4):921-8. PubMed ID: 7707120
    [Abstract] [Full Text] [Related]

  • 17. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
    Hong YS, Lee J, Lee SC, Hwang IG, Choi SH, Heo JS, Park JO, Park YS, Lim HY, Kang WK.
    Cancer Chemother Pharmacol; 2007 Aug 15; 60(3):321-8. PubMed ID: 17143602
    [Abstract] [Full Text] [Related]

  • 18. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED, Hilgenfeld RU, Matthias M, Hoksch B, Boewer C, Oldenkott B, Lenk H, Wiener N, Boese-Landgraf J, Schalhorn A.
    Semin Oncol; 1992 Apr 15; 19(2 Suppl 4):57-62. PubMed ID: 1553576
    [Abstract] [Full Text] [Related]

  • 19. Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie.
    Ravaud A, Audhuy B, Gomez F, Escudier B, Lesimple T, Chevreau C, Douillard JY, Caty A, Geoffrois L, Ferrero JM, Linassier C, Drevon M, Négrier S.
    J Clin Oncol; 1998 Aug 15; 16(8):2728-32. PubMed ID: 9704724
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.